top of page

Portfolio Review - Biotechs

Thu, Apr 16

|

The HIVE by Kadans Science Partner

Seroba Life Sciences will share it's investment strategy and priorities for 2026, to PSCC Connect start-ups only

Portfolio Review - Biotechs
Portfolio Review - Biotechs

Time & Location

Apr 16, 2026, 5:30 PM – 7:00 PM

The HIVE by Kadans Science Partner, 125 rue Edouard Vaillant, 94800 Villejuif, France

About the event

Investor Talks is a new event series dedicated to PSCC Connect start-ups only : an unfiltered meeting giving entrepreneurs direct access to leading investors in  life sciences.


For the second edition, we will welcome Bruno Montanari, Partner at Seroba Life Sciences who will introduce Seroba's strategy for 2026. 


Programme:

  • Seroba Life Sciences — portfolio vision and investment priorities for 2026

  • How investors evaluate emerging biotechs and medtechs

  • What makes a company truly investable in today's competitive funding landscape

  • The most common pitfalls startups face when approaching VC firms

 

From how VCs truly assess opportunities to the type of relationships they seek to build, participants will gain practical, no-filter insights to better navigate their fundraising journey.


Google Maps were blocked due to your Analytics and functional cookie settings.

Share this event

bottom of page